Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
QuintilesIMS
Boehringer Ingelheim
US Department of Justice
Queensland Health
Baxter
Farmers Insurance
Accenture
Mallinckrodt
Chinese Patent Office

Generated: February 25, 2018

DrugPatentWatch Database Preview

Erythromycin estolate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for erythromycin estolate and what is the scope of erythromycin estolate freedom to operate?

Erythromycin estolate
is the generic ingredient in three branded drugs marketed by Barr, Ivax Sub Teva Pharms, Watson Labs, Lilly, Dista, Alpharma Us Pharms, G And W Labs Inc, and Life Labs, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and one drug master file entries for erythromycin estolate.
Medical Subject Heading (MeSH) Categories for erythromycin estolate

US Patents and Regulatory Information for erythromycin estolate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062169-001 Oct 17, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly ILOSONE erythromycin estolate SUSPENSION/DROPS;ORAL 061894-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dista ILOSONE erythromycin estolate TABLET, CHEWABLE;ORAL 061895-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly ILOSONE erythromycin estolate SUSPENSION;ORAL 061894-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs Inc ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062169-002 Oct 17, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Life Labs ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062362-001 Dec 17, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly ILOSONE erythromycin estolate CAPSULE;ORAL 061897-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms ERYTHROMYCIN ESTOLATE erythromycin estolate CAPSULE;ORAL 062237-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs ERYTHROMYCIN ESTOLATE erythromycin estolate CAPSULE;ORAL 062087-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062353-001 Nov 18, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Boehringer Ingelheim
Cerilliant
McKesson
Merck
Cantor Fitzgerald
Daiichi Sankyo
US Department of Justice
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot